GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Imagion Biosystems Ltd (ASX:IBX) » Definitions » Days Sales Outstanding

Imagion Biosystems (ASX:IBX) Days Sales Outstanding : 38.95 (As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Imagion Biosystems Days Sales Outstanding?

Imagion Biosystems's average Accounts Receivable for the six months ended in Dec. 2023 was A$0.14 Mil. Imagion Biosystems's Revenue for the six months ended in Dec. 2023 was A$0.68 Mil. Hence, Imagion Biosystems's Days Sales Outstanding for the six months ended in Dec. 2023 was 38.95.

The historical rank and industry rank for Imagion Biosystems's Days Sales Outstanding or its related term are showing as below:

ASX:IBX' s Days Sales Outstanding Range Over the Past 10 Years
Min: 22.16   Med: 86.45   Max: 164.25
Current: 33.91

During the past 7 years, Imagion Biosystems's highest Days Sales Outstanding was 164.25. The lowest was 22.16. And the median was 86.45.

ASX:IBX's Days Sales Outstanding is ranked better than
88.07% of 218 companies
in the Medical Diagnostics & Research industry
Industry Median: 69.44 vs ASX:IBX: 33.91

Imagion Biosystems's Days Sales Outstanding declined from Dec. 2022 (67.12) to Dec. 2023 (38.95).


Imagion Biosystems Days Sales Outstanding Historical Data

The historical data trend for Imagion Biosystems's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Imagion Biosystems Days Sales Outstanding Chart

Imagion Biosystems Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Sales Outstanding
Get a 7-Day Free Trial 124.33 - 48.56 47.46 22.16

Imagion Biosystems Semi-Annual Data
Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 145.43 31.56 67.12 40.60 38.95

Competitive Comparison of Imagion Biosystems's Days Sales Outstanding

For the Diagnostics & Research subindustry, Imagion Biosystems's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Imagion Biosystems's Days Sales Outstanding Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Imagion Biosystems's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Imagion Biosystems's Days Sales Outstanding falls into.



Imagion Biosystems Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Imagion Biosystems's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

Days Sales Outstanding (A: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (0.092 + 0.074) / 2 ) / 1.367*365
=0.083 / 1.367*365
=22.16

Imagion Biosystems's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

Days Sales Outstanding (Q: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Jun. 2023 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (0.215 + 0.074) / 2 ) / 0.677*365 / 2
=0.1445 / 0.677*365 / 2
=38.95

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Imagion Biosystems  (ASX:IBX) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Imagion Biosystems Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Imagion Biosystems's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Imagion Biosystems (ASX:IBX) Business Description

Traded in Other Exchanges
N/A
Address
5601 Oberlin Drive, Suite 100, San Diego, CA, USA, 92121
Imagion Biosystems Ltd operates in the field of non-invasive detection of specific solid tumor cancers by use of magnetic nanoparticles. The company only operating segment - Research and Development. Its principal business activities consist of nanotechnology, biotechnology, cancer diagnostics and medical imaging using Superparamagnetic Relaxometry. In addition, the company is engaged in the research and development of its clinical phase lead product which is intended for the detection and staging of metastatic HER2 breast cancer.

Imagion Biosystems (ASX:IBX) Headlines

No Headlines